KalVista Pharmaceuticals, Inc. (NASDAQ: KALV), a clinical stage pharmaceutical company focused on the discovery, development, and commercialization of oral, small molecule protease inhibitors, today
DUBLIN (BUSINESS WIRE) The "Global Superdisintegrants Market (2022-2027) by Type, Formulation, Therapeutic Area, Geography, Competitive Analysis, and the Impact of Covid-19 with Ansoff Analysis" report has been added to ResearchAndMarkets.com's offering.The Global Superdisintegrants Market is estimated to be USD 4.
/PRNewswire/ The "Global Superdisintegrants Market (2022-2027) by Type, Formulation, Therapeutic Area, Geography, Competitive Analysis, and the Impact of.
/PRNewswire/ The "Global Superdisintegrants Market (2022-2027) by Type, Formulation, Therapeutic Area, Geography, Competitive Analysis, and the Impact of.